Methyl jasmonate
From Wikipedia, the free encyclopedia
Methyl jasmonate | |
---|---|
IUPAC name | Methyl (1R,2R)-3-Oxo-2-(2Z)-2- pentenyl-cyclopentaneacetate |
Other names | Methyl jasmonate |
Identifiers | |
CAS number | [39924-52-2] |
SMILES | O=C1[C@H](C/C=C\CC) [C@@H](CC(OC)=O)CC1 |
Properties | |
Molecular formula | C13H20O3 |
Molar mass | 224.3 g/mol |
Appearance | Colorless liquid |
Melting point |
<25 °C |
Boiling point |
88-90 °C at 0.1 mmHg |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
Methyl jasmonate (MeJA) is a substance used in plant defense [1]and also under early research for cancer treatment in humans.[1] Plants produce jasmonic acid and methyl jasmonate in response to many biotic and abiotic stresses (particularly herbivory and wounding), which build up in the damaged parts of the plant. Jasmonates act as signaling compounds for the production of phytoalexins. MeJa has been used to stimulate traumatic resin duct production in lodgepole pine trees. This can be used as a defense against many insect attackers as a type of vaccine. Phytoalexins, once ingested by the attacker (e.g., insect), can be toxic or interfere with its digestion and may deter the attacker from further feeding. The jasmonate signal often spreads systemically throughout the plant and is a major component of systemic acquired resistance.
MeJA is also a plant hormone involved in tendril (root) coiling and seed maturation.
[edit] See also
[edit] References
- ^ Flescher E (2005). "Jasmonates--a new family of anti-cancer agents". Anticancer Drugs 16 (9): 911–6. doi: . PMID 16162967.
[edit] External links
- General information about methyl jasmonate
- Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.
- Jasmonate: pharmaceutical composition for treatment of cancer. US Patent Issued on October 22, 2002
- Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells, Leukemia, Nature, April 2002, Volume 16, Number 4, Pages 608-616
- Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells, British Journal of Pharmacology (2005) 146, 800–808. doi:10.1038/sj.bjp.0706394; published online 19 September 2005
|